This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
HCA Healthcare (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $247.03, marking a +0.57% move from the previous day.
Magellan (MGLN) Unit Ties Up to Offer Solution for Older Adults
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - joins forces with DUOS to offer a digital solution for easing the independent living of older adults at homes.
Acadia Healthcare (ACHC) Forms JV to Better Serve Minnesota
by Zacks Equity Research
Acadia Healthcare (ACHC) joins forces with Fairview Health Services for delivering improved behavioral health services throughout the Twin Cities region.
Encompass Health (EHC) Unveils 40-Bed Hospital Plan in Ohio
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct an inpatient rehabilitation hospital in Ohio, which aims to facilitate improved rehabilitation services throughout the state.
Acadia (ACHC) & SCL Health Form JV, Mark 15th Partnership
by Zacks Equity Research
Acadia Healthcare's (ACHC) JV with SCL Health is likely to build a 144-bed freestanding behavioral health unit in the Denver area.
HCA Healthcare (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $245.11 in the latest trading session, marking a +0.41% move from the prior day.
Are Options Traders Betting on a Big Move in HCA Healthcare (HCA) Stock?
by Zacks Equity Research
Investors need to pay close attention to HCA Healthcare (HCA) stock based on the movements in the options market lately.
HCA Healthcare (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $240.51 in the latest trading session, marking a +0.8% move from the prior day.
Encompass Health (EHC) Boosts Texas Presence With Hospital Plan
by Zacks Equity Research
Encompass Health (EHC) aims to deliver better health outcomes by revealing plans to build an inpatient rehabilitation hospital in Texas.
HCA Healthcare (HCA) to Build New Hospitals in Florida
by Zacks Equity Research
HCA Healthcare (HCA) to establish further dominance in the Florida region with new acute care facilities.
Ensign Group (ENSG) Buys Facilities to Boost Real Estate Suite
by Zacks Equity Research
Ensign Group (ENSG) acquires five skilled nursing and assisted living facilities in three U.S. states. The move underscores ENSG's efforts to grow its real estate portfolio and boost U.S. presence.
Acadia Healthcare (ACHC) Inks JV to Boost Chula Vista Presence
by Zacks Equity Research
Acadia Healthcare (ACHC) teams up with Scripps Health in a bid to deliver high-quality behavioral health services across Chula Vista and the neighboring communities.
Encompass Health (EHC) Set to Widen Presence in South Carolina
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct a 27-bed hospital in South Carolina aimed at providing high-quality rehabilitative care throughout the state.
Tenet Healthcare (THC) and USPI Strike SurgeryCenter Deal
by Zacks Equity Research
Tenet Healthcare (THC) along with its subsidiary to acquire SurgCenter Development (SCD) for $1.2 billion.
Why HCA Healthcare (HCA) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Magellan (MGLN) Q3 Earnings Decline Y/Y on Elevated Costs
by Zacks Equity Research
Magellan Health's (MGLN) third-quarter results reflect impact of rising expenses, partly offset by top-line growth and net new business growth in the Healthcare segment.
Select Medical (SEM) Q3 Earnings Beat, Hikes '21 EPS View
by Zacks Equity Research
Select Medical's (SEM) third-quarter results reflect solid revenues driven by strong segmental contributions, and an uptick in admissions and patient visits, partly offset by elevated costs.
Cigna (CI) Q3 Earnings Beat Estimates, Ups '21 EPS View
by Zacks Equity Research
Cigna's (CI) third-quarter results reflect solid segmental performances, consistent expense efficiency and continued medical membership growth.
Humana's (HUM) Earnings Beat Estimates in Q3, Surge Y/Y
by Zacks Equity Research
Humana's (HUM) Q3 results reflect a better revenue stream and strength in its Retail and Healthcare Services segments.
Top Analyst Reports for PayPal, Merck & Caterpillar
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including PayPal Holdings, Inc. (PYPL), Merck & Co., Inc. (MRK), and Caterpillar Inc. (CAT).
Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare Corp. and Acadia Healthcare Company
by Zacks Equity Research
Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare Corp. and Acadia Healthcare Company
Acadia Healthcare (ACHC) Q3 Earnings Meet Estimates, Rise Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q3 results reflect higher revenues, driven by solid demand for its behavioral health services and higher admissions.
MEDNAX's (MD) Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
MEDNAX's (MD) third-quarter results reflect growing revenues driven by rising patient volumes, partly offset by higher general and administrative expenses.